Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ontogen completes phase I multidose oral study of MDR compound

Nov. 17, 1999

Preclinical data highlight Xcytrin's anticancer activity and novel mechanism of action

Nov. 17, 1999

New data reported on thalidomide for several cancer indications

Nov. 17, 1999

OHSU study will evaluate vitamin D in patients with recurring prostate cancer

Nov. 16, 1999

Kotobuki presents new sulfonamide MMP inhibitors

Nov. 15, 1999

Antisense compounds from Isis target human cancer-associated mdm2

Nov. 15, 1999

Photogen teams up with Akorn to advance development of PH-10

Nov. 12, 1999

Preparation and activity of apoptosis inducers disclosed by Takara Shuzo

Nov. 12, 1999

Meiji Milk Products reveals new antiangiogenic agents

Nov. 12, 1999

Combined data from three clinical trials of ibritumomab tiuxetan confirm safety in NHL

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...